October 31, 2025 Q3 2025 Results Stephan B. Tanda, Aptar President and CEO Vanessa Kanu, Executive Vice President and CFO Forward Looking Statements & Non-GAAP Financial Measures This presentation includes forward-looking statements. Forward-looking statements are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and are based on management's beliefs and assumptions in light of information currently available to ma ...

AptarGroup (ATR) reported $961.13 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 5.7%. EPS of $1.62 for the same period compares to $1.49 a year ago.The reported revenue represents a surprise of +0.91% over the Zacks Consensus Estimate of $952.51 million. With the consensus EPS estimate being $1.57, the EPS surprise was +3.18%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determ ...

AptarGroup (ATR) came out with quarterly earnings of $1.62 per share, beating the Zacks Consensus Estimate of $1.57 per share. This compares to earnings of $1.49 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +3.18%. A quarter ago, it was expected that this maker of consumer-product dispensing systems would post earnings of $1.58 per share when it actually produced earnings of $1.66, delivering a surprise of +5.06%.Over the l ...

Aptar Reports Third Quarter 2025 Results Exhibit 99.1 Crystal Lake, Illinois, October 30, 2025 -- AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dosing, dispensing and protection technologies, today reported the following third quarter results for the period ended September 30, 2025, as compared to the corresponding period of the last fiscal year. Third Quarter 2025 Highlights (Compared to the prior year quarter; see Non-GAAP section for full definitions; see reconciliati ...

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Reports Third Quarter 2025 Results. ...

Key Takeaways The Industrial Products sector is expected to post 1.2% earnings and 9% revenue growth in Q3 2025.AptarGroup, Tennant and Sealed Air show positive Earnings ESPs and strong fundamentals for Q3.Demand across life sciences, automation and e-commerce packaging continues to fuel performance.The Zacks Industrial Products sector kicked off the third quarter of 2025 earnings season last week. The sector is anticipated to have performed well in the quarter, backed by strength across key end markets, gr ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Group 1 - AptarGroup, Inc. received FDA 510(k) clearance for HeroTracker Sense, a Bluetooth-enabled sensor for inhalers [1] - HeroTracker Sense connects inhalers to a smartphone app, providing reminders, educational tips, and real-time feedback [1] - Following the FDA approval, a Buy rating was reiterated by Matt Roberts from Raymond James with a price target of $172 [2] Group 2 - AptarGroup designs and manufactures dosing, dispensing, and protection technologies for various products [2]

Industry Overview - The Zacks Containers - Paper and Packaging industry is expected to benefit from increasing packaging requirements driven by e-commerce growth and steady demand from consumer-oriented markets like food, beverages, and healthcare [1][4] - The industry is also experiencing a rising demand for sustainable and eco-friendly packaging options due to heightened environmental concerns [1][5] - Companies in this industry are implementing pricing strategies to offset rising costs from tariffs and raw materials [1][6] Demand Drivers - E-commerce is projected to surge, leading to stable demand for packaging applications, which are crucial for maintaining product integrity during delivery [4] - The industry's significant exposure (over 60%) to consumer-oriented markets ensures consistent demand across economic cycles [4] Eco-Friendly Trends - There is a growing preference for biodegradable packaging materials, driven by increased consumer awareness [5] - Industry players are adopting new technologies and incorporating recycled content into their production methods to meet this demand [5] Pricing and Cost Management - Higher raw material and labor costs, along with labor shortages and tariffs, are pressuring margins [6] - Companies are streamlining operations and implementing cost-reduction actions to mitigate these challenges [6] Industry Performance - The Zacks Containers - Paper and Packaging industry currently holds a Zacks Industry Rank of 95, placing it in the top 39% of 243 Zacks industries, indicating positive prospects [7][8] - However, the industry has underperformed compared to its sector and the S&P 500 over the past year, declining 34.7% against the sector's growth of 2.4% and the S&P 500's gain of 19% [9] Valuation Metrics - The industry is trading at a forward 12-month EV/EBITDA ratio of 15.98X, compared to the S&P 500's 13.79X and the Industrial Products sector's 23.92X [12] - Over the past five years, the industry has traded between 14.54X and 24.25X, with a median of 20.58X [17] Company Highlights - **AptarGroup**: The Pharma segment is seeing strong demand for drug delivery systems, and the company has a Zacks Rank of 2 (Buy) with a projected earnings growth of 4.3% for fiscal 2025 [18][19] - **Karat Packaging**: Positioned to benefit from eco-friendly product demand and expanding manufacturing capabilities, with a Zacks Rank of 2 and a projected earnings growth of 0.6% for 2025 [21][23] - **Brambles**: Focused on digital initiatives for growth and efficiency, with a Zacks Rank of 3 (Hold) and an expected earnings growth of 8.7% [26][27] - **Packaging Corporation of America**: Strong demand in e-commerce and stable demand for food packaging, with a Zacks Rank of 3 and projected earnings growth of 13.5% for fiscal 2025 [30][31] - **Sealed Air**: Benefiting from e-commerce growth and demand for recyclable materials, with a Zacks Rank of 3 and projected earnings growth of 13.5% [32][35]

Core Insights - Rakovina Therapeutics presented new data on its AI-driven kt-5000AI drug discovery program for ATR inhibitors at the AACR-NCI-EORTC conference, highlighting promising results for cancer therapy targeting CNS penetration [1][2][3] Company Developments - The collaboration with Variational AI utilized the Enki™ generative AI platform to identify novel small-molecule candidates for CNS-penetrant ATR inhibition, with multiple lead compounds achieving the desired profile [2][3] - Rakovina's kt-5000AI program is advancing next-generation ATR inhibitors that have confirmed CNS exposure, potentially benefiting patients with primary brain tumors and brain metastases [3][5] - The company aims to advance one or more drug candidates into human clinical trials in collaboration with pharmaceutical partners [6] Scientific Findings - In cell-based assays, lead compounds demonstrated over 50% inhibition of ATR activity below 200 nM, with potency exceeding reference compounds such as ceralasertib, tuvusertib, and elimusertib [7] - In vivo pharmacokinetic studies showed measurable drug concentrations in plasma and brain tissue after intraperitoneal dosing at 5 mg/kg, indicating CNS penetration and good tolerability after single-dose administration [7]